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Abstract
Tuberculosis (TB) remains a global health pandemic and greater understanding of underly-
ing pathogenesis is required to develop novel therapeutic and diagnostic approaches. Ma-
trix metalloproteinases (MMPs) are emerging as key effectors of tissue destruction in TB
but have not been comprehensively studied in plasma, nor have gender differences been
investigated. We measured the plasma concentrations of MMPs in a carefully character-
ised, prospectively recruited clinical cohort of 380 individuals. The collagenases, MMP-1
and MMP-8, were elevated in plasma of patients with pulmonary TB relative to healthy con-
trols, and MMP-7 (matrilysin) and MMP-9 (gelatinase B) were also increased. MMP-8 was
TB-specific (p<0.001), not being elevated in symptomatic controls (symptoms suspicious of
TB but active disease excluded). Plasma MMP-8 concentrations inversely correlated with
body mass index. Plasma MMP-8 concentration was 1.51-fold higher in males than females
with TB (p<0.05) and this difference was not due to greater disease severity in men. Gen-
der-specific analysis of MMPs demonstrated consistent increase in MMP-1 and -8 in TB,
but MMP-8 was a better discriminator for TB in men. Plasma collagenases are elevated in
pulmonary TB and differ between men and women. Gender must be considered in investi-
gation of TB immunopathology and development of novel diagnostic markers.
Introduction
Tuberculosis (TB) remains a severe global health problem with 9.0 million new cases and
1.5 million deaths in 2013 [1]. Multidrug resistant and extensively drug-resistant TB cases are
rising [1] and “totally drug-resistant TB” has been reported in Iran, India and South Africa [2].
PLOSONE | DOI:10.1371/journal.pone.0117605 January 30, 2015 1 / 15
a11111
OPEN ACCESS
Citation: Sathyamoorthy T, Sandhu G, Tezera LB,
Thomas R, Singhania A, Woelk CH, et al. (2015)
Gender-Dependent Differences in Plasma Matrix
Metalloproteinase-8 Elevated in Pulmonary
Tuberculosis. PLoS ONE 10(1): e0117605.
doi:10.1371/journal.pone.0117605
Academic Editor: Yves St-Pierre, INRS, CANADA
Received: June 10, 2014
Accepted: December 29, 2014
Published: January 30, 2015
Copyright: © 2015 Sathyamoorthy et al. This is an
open access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: TS was funded by an MRC and GS by a
Wellcome Clinical Research training fellowship. PE
and JSF are grateful for support from the National
Institute for Health Research (NIHR) Biomedical
Research Centre (BRC) funding scheme at Imperial
College. The authors are grateful for support from the
Imperial College Healthcare Charity. The funders had
no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
To develop new therapeutic and diagnostic approaches, it is critical to understand underlying
mechanisms of disease. Pulmonary tissue damage is characteristic of tuberculosis and is a con-
sequence of immunopathology driven by the host response toMycobacterium tuberculosis
(Mtb). Pulmonary extracellular matrix (ECM) breakdown and subsequent cavitation results in
morbidity, mortality [3] and facilitates transmission [4–6]. TB is more common in males than
females, with a 1.9-fold excess in case notification globally, which may result from both socio-
logical and biological factors [7–10]. However, although some evidence of biological differences
in TB between men and women exists, this has historically been overlooked by the field [7,11].
The matrix metalloproteinases (MMPs) are proteases able to degrade all components of the
pulmonary extracellular matrix [12,13] and therefore are implicated in the pathology of cavi-
tary pulmonary TB [14]. Accumulating evidence implicates the MMPs in tissue destruction in
TB, in particular MMP-1 driving collagenolysis [15,16] and MMP-9 regulating cellular recruit-
ment to the granuloma [17]. MMP-8 and MMP-9 are principally derived from neutrophils and
are contained within granules [18]. MMP-8 (neutrophil collagenase) can degrade collagen and
has been implicated in other destructive lung pathologies [19]. Neutrophils are relatively
unique in that they store pre-synthesised MMP-8, and neutrophils are emerging as key patho-
logical mediators at the time of TB diagnosis [20,21]. Circulating MMPs have not previously
been systematically investigated in TB, in particular including the important control group of
respiratory symptomatics (patients with symptoms suspicious of TB but sputum culture nega-
tive). MMPs are most appropriately analysed in plasma samples [22] and concentrations have
been reported to differ between men and women [23].
Analysis of circulating inflammatory mediators in TB, such as cytokines and chemokines, in
plasma and serum to define underlying mechanisms of pathogenesis has generally shown sur-
prisingly small differences between patients with TB and control groups [24,25]. In addition,
these investigations generally do not consider gender differences [24]. We hypothesised that
MMPs, as final effectors of immunopathology in TB, may identify greater divergence between
groups. We analysed plasma concentrations of MMPs in a prospectively collected cohort of
380 patients with active tuberculosis, healthy controls, and the key comparator group of respi-
ratory symptomatics. We demonstrate that circulating collagenases are elevated in TB, further
implicating collagenase activity in driving immune-mediated tissue damage, and identify
MMP-8 as a novel marker of TB compared to other respiratory infections. MMP-8 concentra-
tions are higher in men than women with TB, highlighting a previously overlooked potential
confounder in the investigation of TB pathology and assessment of novel diagnostic strategies.
Methods
Ethics statement
All participants gave written informed consent and the research was approved by internation-
ally accredited ethics committees at Universidad Peruana Cayetano Heredia (Lima, Peru) and
Imperial College London (London, United Kingdom).
Study design
SELDI-TOF proteomic analyses of a subset of these plasma samples along with baseline clinical
characteristics of those patients have previously been reported [26]. Participants were recruited
over a 2 year period from 16 community TB clinics serving the shantytown of Ventanilla in
Lima, Peru. The clinical management of patients was not altered from the standardised regime,
and all patients provided four consecutive sputum samples for microscopy and culture. Pa-
tients with active TB were recruited on the basis of positive sputum microscopy with subse-
quent confirmation by culture. Symptomatic controls were those who had symptoms
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suspicious of TB (persistent cough and 2 or more features from fever, weight loss, decreased
appetite or haemoptysis) but in whom active TB was subsequently excluded by sputum micros-
copy and negative sputum culture. This group was deemed to have an alternative respiratory
infection and described as “respiratory symptomatics”. Healthy controls were recruited from
randomly selected households in the community where patients with active TB were not resi-
dent. Informed consent was given by or on behalf of all participants.
Sample collection
A 4 ml blood sample was obtained from each participant either before initiation of treatment
or within 48 hours of starting treatment. Blood was collected in EDTA and transferred to the
laboratory on ice. The plasma was separated (3500 rpm, 10 minutes), aliquotted in 1.5ml cryo-
vials and frozen at -70°C for subsequent analysis [26].
Luminex assay
The samples were defrosted at 4°C and 50μl aliquots were placed in 96 well plates before re-
freezing at -70°C. This minimized freeze thaw cycles of the samples prior to analysis. Analysis
used MMP beads (R&D systems, Abingdon, UK) on the Luminex 200 platform (Biorad Bioplex
200, Hemel Hempstead), as per manufacturer’s instructions for MMP-1, -2, -3, -7, -8, -9, -10,
-12 and-13. The lower level of detection of the assay was 1.1, 12.6, 7.3, 6.6, 16.6, 13.7, 3.2, 0.7
and 63.5pcg/ml respectively. In preliminary studies, MMP-12 and MMP-13 were not detected
in plasma of either control or TB patients and so were not studied further. MMP-2 was de-
tected but was excluded from statistical analysis as it was present in the plasma at high baseline
concentrations and mean fluorescence intensity (MFI) values were predominantly above the
assay range.
Statistical analysis
The luminex output was exported into Microsoft Excel and a master data file compiled inte-
grating the clinical characteristics with laboratory values. Initial statistical analysis was per-
formed using GraphPad Prism 5. MannWhitney U test was used to compare paired values and
OneWay Analysis of Variance (ANOVA) with Tukey’s post hoc analysis for multiple compari-
sons. The multivariate analysis using a stepwise logistic regression conditional model was per-
formed in SPSS version 22.
Principal component analysis (PCA) was conducted using the FactoMineR / scatter-
plot3d / rgl packages in R version 3.0.2. To account for missing values within the dataset, the
missMDA package in R was used, which performs imputation for missing values with multi-
variate data analysis methods. ROC curves were generated using R version 2.15.2 using the
package pROC and Youden’s index was used to calculate an optimal cut off threshold in
each case.
Results
Baseline patient characteristics
120 healthy controls, 109 symptomatic controls and 151 patients with active pulmonary TB
were recruited (clinical characteristics of cohort, Table 1). The groups were well matched for
age, but there were higher proportions of females in the healthy and symptomatic controls
group (66% for both) and a higher proportion of males in the active TB group (56%). All
the patients with active TB were either smear or culture positive with 92% smear and culture
positive. All symptomatic controls were smear and culture negative. There was a lower
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proportion of patients with past TB in the healthy controls (3%) but similar proportion in the
symptomatic controls (17%) and active TB (23%). Patients with active TB had lower body
mass index (BMI) at enrolment compared with symptomatic controls and healthy controls
(21.66 vs. 24.15 and 25.86 respectively). Symptomatic controls and patients with active TB
had overlapping clinical symptoms, although the duration was longer in the TB group (median
7 days vs. 2 days).
Plasma MMP-1 and MMP-8 are elevated in pulmonary TB and MMP-8 is
TB-specific
We analysed concentrations of MMP-1, -3, -7, -8, -9 and, -10 in the plasma of all patients.
MMP-1 (interstitial collagenase) was increased in both active pulmonary TB and respiratory
symptomatics compared with healthy controls (p<0.001 and<0.01 respectively), but there was
no difference between active TB and respiratory symptomatics (Fig. 1A). MMP-8 (neutrophil
collagenase) was specifically increased in the plasma of patients with active TB compared to
both respiratory symptomatics and healthy controls (Fig. 1D, both p<0.001). There was no sig-
nificant difference between symptomatics and healthy controls. MMP-7 (matrilysin) was in-
creased in both active pulmonary TB and symptomatics compared healthy controls (p<0.01 for
both), but there was no difference between active TB and symptomatics (Fig. 1C). However, the
median MMP-7 value in respiratory symptomatics was higher at 66.3pg/ ml compared to
20.1pg/ml in both pulmonary TB and healthy controls, suggesting that plasmaMMP-7 is
Table 1. Demographic and clinical characteristics.
Patient characteristics Healthy controls Respiratory
Symptomatics
TB
n % n % n %
Patients 120 31 109 29 151 40
Age (years)* 31 (23–40) 32 (24.5–47.5) 28.5 (22–38)
Sex ratio Male: Female 41:79 34:66 37:72 34:66 85:66 56:44
Sputum smear
Positive - - 0 0 139 92
Negative - - 109 100 12 8
Sputum culture
Positive - - 0 0 139 92
Negative - - 109 100 12 8
History of past TB 4 3 19 17 34 23
BMI** 25.86 (4.33) 24.15 (4.67) 21.66 (2.97)
Presence of symptoms / signs
Cough 42 35 109 100 154 100
Haemoptysis 2 2 28 26 71 47
Fever 17 14 52 48 93 62
Weight loss 40 33 72 66 123 81
Appetite loss 23 19 57 52 109 72
Symptoms duration (days)* 0 2 (1–10) 7 (1–30)
Abbreviations: IQR—Interquartile range, BMI—Body Mass Index.
*Median (IQR);
**Mean (SD)
doi:10.1371/journal.pone.0117605.t001
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Fig 1. Neutrophil collagenaseMMP-8 is specifically upregulated in the plasma in active pulmonary
tuberculosis (TB). Plasma samples were collected prospectively from patients in Lima, Peru. MMP
concentrations were measured by Luminex bead array.A. MMP-1 was increased in both active TB and
respiratory symptomatics compared to healthy controls (p<0.001 and 0.01 respectively). B. MMP-3 showed
no difference between the groups.C. MMP-7 was increased in both active TB and symptomatic controls
compared to healthy controls (p<0.01 for both). D. MMP-8 was specifically increased in active TB compared
to both respiratory symptomatics and healthy controls (p<0.001 for both). E. MMP-9 was increased in active
TB only compared to healthy controls (p<0.05). F. MMP-10 showed no difference between the groups.
Statistical analysis was performed using a one way ANOVA with Tukey’s post hoc test, ***p<0.001,
**p<0.01, *p<0.05. Each box represents the 25th to 75th centiles, the central line the median, and the
whiskers the minimum and maximum values.
doi:10.1371/journal.pone.0117605.g001
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elevated in a small proportion of patients with TB. MMP-9 was increased in active TB only com-
pared to healthy controls (Fig. 1E, p<0.05). There was no statistically significant difference in
MMP-9 between active TB and symptomatic controls or symptomatic controls and healthy con-
trols. MMP-3 andMMP-10 showed no difference between any of the groups (Fig. 1B and 1F).
Within the control group, patients were classified as either having latent TB, with a positive
interferon gamma release assay (IGRA), or not TB-exposed, with a negative IGRA. Analysis of
control patients according to IGRA status did not demonstrate significant differences for the
majority of MMPs (Fig. A in S1 File), but plasma MMP-7 concentrations were significantly ele-
vated in patients with latent TB. When MMP concentrations were analysed against baseline
clinical characteristics, the strongest association was an inverse correlation between plasma
MMP-8 and body mass index (Fig. 2, rho-0.460).
Plasma MMP-8 is higher in males with TB than females with TB
Previously, MMP-3, MMP-8 and MMP-9 have been observed to be higher in males than in fe-
males [23]. Therefore, we analysed MMPs according to gender. In our cohort, MMP-1, MMP-
3, MMP-8 and MMP-9 were higher in males when all patients were analysed together. In the
cohort, the active TB group had a higher proportion of males while symptomatic controls had
more females, potentially introducing a confounder, and therefore MMP concentrations were
analysed in patients with TB only. In the TB group, MMP-8 was significantly elevated in males
versus females (Fig. 3A, p = 0.021). The increased MMP-8 concentrations may result either
from males presenting with more severe disease, or alternatively, MMP-8 concentrations being
independently higher in males with TB. To address this question both stratified analysis and
multivariate analysis were performed. In the stratified analysis, we compared the sputum AFB
load, duration of weight loss and duration of cough between genders only in the patients with
TB, to determine if males had more severe or prolonged disease. There was no difference in
sputum smear or weight loss between genders (Fig. 3B and Fig. 3C), but cough duration in
males was more prolonged (Fig. 3D), which may reflect either greater pulmonary pathology in
men or delayed presentation.
Analysis of the relationship between plasma MMP-8 concentrations and sputum smear, du-
ration of weight loss or duration of cough did not demonstrate any significant correlations,
again indicating that elevated MMP-8 concentrations were not due to greater disease severity
or delayed diagnosis. In a multivariate analysis, we analysed patients with TB versus controls
Fig 2. Plasma MMP-8 concentration inversely correlates with BMI. Analysis of plasmaMMP-8
concentration and BMI shows an inverse relationship by Spearman’s correlation (Rho = -0.460, p<0.001).
doi:10.1371/journal.pone.0117605.g002
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and patients with respiratory symptomatics and performed a backward stepwise logistic regres-
sion model to determine whether these variables are independent predictors of TB (Table 2).
We found that MMP-8 is an independent predictor of TB status as adjusted for gender, dura-
tion of weight loss and duration of cough as markers of the duration/severity of the disease.
Gender was an independent predictor in this model, again demonstrating that the elevated
MMP-8 concentrations in males were not due to delayed presentation.
Next, we analysed plasma MMPs individually for each gender. MMP-1 remained increased
in both active TB and symptomatics compared to healthy controls for males (Fig. 4A, p<0.01
and<0.05 respectively), but in females MMP-1 was only increased in active TB compared to
healthy controls (Fig. 4B, p<0.01). MMP-8 remained increased in active TB compared to both
symptomatics and healthy controls in males (Fig. 4C, p< 0.05 and<0.01 respectively) and fe-
males (Fig. 4D, p< 0.01 and<0.05 respectively). MMP-3 and MMP-9 showed no significant
differences between the three clinical groups for the sexes when analysed separately. The
Fig 3. Analysis of clinical and laboratory parameters in patients with TB by gender. A. Amongst
patients with TB, MMP-8 was analyzed by gender. PlasmaMMP-8 concentrations were higher in males than
females.B. There was no significant difference in sputummycobacterial load between genders as analyzed
by sputum smear quantitation.C. There was no difference in duration of weight loss between men and
women with TB. D. Men with TB had a greater duration of cough than women at time of diagnosis of TB.
Statistical analysis was performed using Mann-Whitney U Test, *p<0.05, NS Not significant.
doi:10.1371/journal.pone.0117605.g003
Gender-Dependent MMP-8 Differences in Tuberculosis
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median values and interquartile ranges for MMP-1, MMP-3, MMP-8 and MMP-9 for the sexes
separately and across the three clinical groups are provided in Table A in S1 File.
Principal component analysis demonstrates distinction between TB and
control patients but not respiratory symptomatics
We next investigated association between key clinical features of TB documented at time of re-
cruitment and plasma MMP concentrations by principal component analysis (PCA). First, we
analysed the relationship between variables when principle components are calculated based
on their values across samples, analysing circulating MMPs and clinical characteristics such as
cough, body mass index (BMI), sex, sputum smear result, tuberculin skin test (TST) and inter-
feron-gamma release assay (IGRA). MMP-1, -7, -8 and-9 were included in the analysis as they
significantly differed in the initial plasma analysis (Fig. 5A). MMP-8 and-9 cluster together,
suggesting that both have a common source and these proteases are co-secreted by neutrophils.
BMI and sex were similarly closely associated, as would be predicted from anthropometry.
MMP-1 associated with cough, which may imply a mechanistic link.
Next, we performed analysis of the relationship between samples when principle compo-
nents are calculated based on the variable values in each sample. We combined discriminatory
clinical and laboratory continuous variables (BMI, IGRA concentration, MMP-1, MMP-7,
MMP-8 and MMP-9) to determine whether this analytical approach differentiated between pa-
tient groups. As MMPs differed between gender, analysis was performed separately for males
and females. Comparison between healthy controls and TB patients showed separation of
groups (Fig. 5B and C). However, when the same analysis was performed for TB against respi-
ratory symptomatics, there was greater overlap between the groups (Fig. 5D and E), suggesting
that this multiparameter approach using these variables alone will not provide a robust separa-
tion of patients with TB from respiratory symptomatics.
Plasma MMP-8 differentiates patients with active pulmonary TB from
symptomatic controls
We then performed receiver operating characteristic (ROC) analysis utilising MMP-8 as a sin-
gle variable, since this had differed most significantly between patients with TB and respiratory
symptomatics. The area under the curve (AUC) was 0.77 for all genders with a Youden’s crite-
ria for optimal cut-off of MMP-8 = 6600 pg/ml with a specificity of 77.3% and sensitivity of
64.3% (Fig. B in S1 File). When ROC curves were plotted separately for males and females,
Table 2. Multivariate analysis of TB status.
Variable Odds ratio Exp (B) 95% CI for EXP (B) p-value
MMP-8* (pg/ml) 2.73 2.05 3.64 <0.001
Gender (M/F) 1.84 1.13 2.98 0.014
Duration of cough (days) 1.01 1.00 1.02 0.011
Weight loss (weeks) 1.02 0.99 1.04 0.067**
A backward stepwise logistic regression model was built to predict TB status in 380 patients using plasma
MMP-8 concentration as adjusted for gender, duration of cough and duration of weight loss as covariates.
*Log-transformed values of MMP-8 are used.
**Marginal signiﬁcance.
doi:10.1371/journal.pone.0117605.t002
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plasma MMP-8 has a greater predictive ability for active TB in men compared to women
(Fig. 6). For men the AUC is 0.80 with a Youden’s criteria of 6967 pg/ml and a higher specifici-
ty (80.8%) and sensitivity (68.2%.). For women the AUC is 0.72 with a lower Youden’s criteria
of 3780 pg/ml and a lower specificity (57%) though a higher sensitivity (79.7%) than the ROC
curve for the sexes combined or men alone.
Discussion
We prospectively recruited and carefully characterised a cohort of 380 patients with active pul-
monary TB, respiratory symptomatics (symptoms suspicious of TB but active disease exclud-
ed) and healthy controls. We report the first comprehensive analysis of circulating MMPs
including the key comparator group of respiratory symptomatics. Two collagenases, MMP-1
and MMP-8, were elevated in active TB, but MMP-8 is specifically upregulated in TB com-
pared to both symptomatics and healthy controls. Critically, MMP-8 was higher in males than
females, potentially introducing an important confounder. Analysis of the sexes separately
Fig 4. Plasma MMP-1 and MMP-8 remain elevated in TB when analysed by gender. As there was a
higher proportion of males in the TB group, plasmaMMP-1 and MMP-8 concentrations were analysed
individually for males and females in each group.A. In males, MMP-1 was increased in active TB and
symptomatics compared to healthy controls.B. In females, MMP-1 was only increased in active TB
compared to healthy controls.C, D. In males (C) and females (D), MMP-8 was specifically increased in active
TB only compared to symptomatic controls and healthy controls. Statistical analysis was performed using a
one way ANOVA with Tukey’s post hoc test, **p<0.01, * p<0.05.
doi:10.1371/journal.pone.0117605.g004
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Fig 5. Prinicipal component analysis (PCA) demonstrates discrimination between TB and controls,
but not between TB and respiratory symptomatics. A. Three dimensional PCA plot demonstrating the
association between different analytes. Individual points represent a single analyte and the distance between
points reflects their Pearson correlation coefficient, whereby a short distance demonstrates close correlation.
Two projections are shown purely for visualization purposes, demonstrating close correlation between MMP-
8 and 9, BMI and sex, and MMP-1 and cough respectively. B-E. Three dimensional network principal
component analysis plots generated using key parameters that differed between patients with TB and
controls. Measurements for MMP-1, MMP-7, MMP-8, MMP-9, BMI and IFN-γ were log2 transformed and
visualized for each gender using PCA plots using the rgl package in R. The colour of the circle represents
patient status, red indicating healthy controls, blue TB and yellow respiratory symptomatics. Distinction
between patient groups is seen between healthy controls and TB for males (B) and females (C), but between
TB and respiratory symptomatics there is much greater overlap (D, males, E, females).
doi:10.1371/journal.pone.0117605.g005
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Fig 6. Plasma MMP-8may discriminate patients with active pulmonary tuberculosis (TB) from
symptomatic controls, but has better predictive value for men than women. A receiver operating
characteristic (ROC) curve was plotted to investigate whether plasmaMMP-8 concentrations discriminated
between active pulmonary TB and respiratory symptomatics. The area under the curve (AUC) indicates
predictive ability and is greater for men than women. AUC: area under curve, Spec: specificity,
Sens: sensitivity.
doi:10.1371/journal.pone.0117605.g006
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confirmed that MMP-8 is increased in active TB compared to symptomatics and controls.
These data demonstrate that gender needs to be considered in investigation of TB immunopa-
thology and novel diagnostic markers.
Previous studies have primarily assessed MMPs at the primary site of TB disease rather than
in the circulation. MMPs-1, -2, -3 and-8 were increased in the induced sputum of patients with
pulmonary TB and MMP-1 correlated with extent of radiological infiltration [15,16]. In con-
trast, in our study of circulating MMPs, the collagenase MMP-8 was most elevated in patients
with TB compared to respiratory symptomatics, demonstrating that different immunological
mediators predominate in each compartment. This suggests that measuring biomarkers at the
site of disease and within the circulation may not identify the same pathological mediators, and
that plasma analysis may not reflect the processes within the lung interstitium. MMP-8 is prin-
cipally neutrophil-derived and its principal substrate is thought to be fibrillar collagen [27].
Collagen is the primary structural fibril of the pulmonary ECM and our findings support the
hypothesis that excessive collagenolytic activity is critical to the tissue destruction that occurs
in pulmonary TB [14]. Doxycycline, a widely available antibiotic, also inhibits MMP activity at
sub-antimicrobial concentrations, and so our data further support the potential use of doxycy-
cline as a host-directed therapy to limit immunopathology in TB [16]. The elevation of MMP-
8, and the close association with MMP-9 on principal component analysis, suggests that neu-
trophils are the primary source of MMP-8, which are emerging as key mediators of pathology
at time of TB diagnosis [20,21].
Plasma MMPs in tuberculosis have previously been investigated in smaller cohorts of pa-
tients. These studies have shown elevated MMP-8 and MMP-9, but none of these studies in-
cluded respiratory symptomatic controls [28–30]. Also consistent with our findings, a recent
study using aptamers for proteomic profiling of paired serum of TB patients at enrolment and
after 8 weeks of TB chemotherapy showed that MMP-1, -8 and-9 fell during treatment [25].
The elevation of MMP-8 in TB compared to respiratory symptomatics contrasts with CRP,
which has been reported to be more elevated in other respiratory conditions [31]. Investigation
of plasma MMPs in other respiratory infections have shown that plasma MMP-9 is elevated in
community acquired pneumonia compared to healthy controls and in two studies, MMP-9
was found to return to normal after antibiotic treatment [32–34]. In a study of hospital ac-
quired pneumonia, MMP-8 and MMP-9 were elevated in both the bronchoalveolar lavage
fluid and plasma of patients compared to healthy controls [35]. These findings are consistent
with our data and suggest that MMPs may be peripheral markers of immune-mediated
tissue damage.
We analyzed a cross-sectional study of patients with smear positive pulmonary disease and
demonstrated differences in plasma MMPs compared to healthy controls. In addition, plasma
MMP-7 was elevated in patients with latent TB relative to IGRA negative controls. MMP-7 has
previously been implicated in TB-IRIS [36]. Large-scale population studies would be required
to determine whether increased MMP-7 associates with an increased risk of developing active
TB and is a marker of low-level disease activity. Important follow-up studies will be to compare
pulmonary disease, where bacillary loads are high, with paucibacillary TB disease to determine
whether MMPs diverge between these clinical presentations. In addition, a key subsequent
study will be to determine the changes in plasma MMPs during TB treatment. We have previ-
ously shown that MMP concentrations in induced sputum correlate with treatment outcome
[37], but are not aware of longitudinal studies of plasma MMPs during treatment.
Differences in plasma MMPs between men and women have been previously identified [23]
and we confirmed in our study that MMP-8 was significantly higher in men with TB and this
was not due to the potential confounder of delayed presentation. Men mount a greater and
often more damaging inflammatory response to infection compared to women of reproductive
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age [38]. A proposed mechanism is that female sex hormones are protective [39] and female
neutrophils have been found to express decreased MMP-9 during the period of the menstrual
cycle when oestrogen levels are higher [40]. Clinical features of TB infection differ between
men and women, although the biology is very poorly understood [7,11]. For example, men
have a higher reported incidence of TB [9,10] and present more commonly with smear positive
pulmonary disease [41]. Men have greater infiltrates on chest radiograph and more frequent
haemoptysis [10]. In contrast, women more frequently develop lower zone pulmonary infil-
trates [42]. These epidemiological observations demonstrate divergent immunopathology be-
tween sexes in human TB and are consistent with the hypothesis that differences in MMP
expression causes greater tissue destruction in men [10]. The gender differences in plasma
MMP-8 concentrations that we identify demonstrate a previously overlooked potential con-
founder in the assessment of novel TB diagnostic tests, which currently do not discriminate be-
tween men and women [24].
In summary, plasma MMP-1 and MMP-8 are elevated in active pulmonary TB, implicating
excessive collagenase activity in TB immunopathology. MMP-8 is TB-specific and is higher in
TB than in respiratory symptomatics. Plasma MMP-8 concentrations differ between men and
women, demonstrating that gender must be considered in the investigation of TB pathology
and development of novel TB diagnostics.
Supporting Information
S1 File. Table A. Plasma MMP concentrations are higher in men than women.Median levels
and interquartile ranges (in brackets) for plasma matrix metalloproteinases (MMPs) analysed
separately according to gender, for the entire cohort and separately by patient groups. Abbrevi-
ations: N/A—Not analysed. Fig. A. Plasma MMP-7 concentrations are higher in healthy
controls with a positive IGRA than those with a negative IGRA. Plasma MMP concentra-
tions analyzed by luminex array were compared by unpaired t-test. MMP-7 concentrations
were significantly higher in individuals with a positive IGRA than a negative IGRA. Fig. B.
Plasma MMP-8 may discriminate patients with active pulmonary tuberculosis (TB) from
symptomatic controls. A receiver operating characteristic (ROC) curve was plotted to investi-
gate whether plasma MMP-8 concentrations discriminated between active pulmonary TB and
respiratory symptomatics. The area under the curve (AUC) was 0.77 indicating moderately
high predictive ability. The optimal cut off was MMP-8 = 6600 pg/ml with specificity 77.3%
and sensitivity 64.3%.
(PDF)
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